The history of Viagra, initially marketed by copyright, presents a complex case study for stakeholders considering the pharmaceutical sector. While its initial success and impact of countless in sales, the exclusivity lapse has opened the floodgates for alternative medications, significantly diminishing earnings prospects . This shift raises doubts